In a podcast recorded at the 2017 SB3C summer conference, Prof. Yaling Liu, Lehigh University, discusses his work using microfluidic devices to capture circulating tumor cells.
Georgia Tech researchers have developed a way to remotely activate the modified T cells from outside the body using a near-infrared laser that very precisely targets cancerous tumors.
Ronald Zuckermann, director of the Molecular Foundry at Lawrence Berkeley National Laboratory, and his colleagues have created a two-dimensional sugar-coated nanosheet that mimics the surface of cells and, in doing so, can selectively target pathogens like viruses and bacteria.
It’s no secret that most biomedical firms today use modeling to make research and development decisions. What remains to be seen is how to take modeling, within companies and among regulatory agencies, to the next level.